TRAVERE THERAPEUTICS, INC. (TVTX) Capital expenditures 2016–2023
TRAVERE THERAPEUTICS, INC. (TVTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$668,000FY2023 · since FY2016: $1.4M → $668,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $668,000 | +249.7% |
| FY2022 | $191,000 | -96.3% |
| FY2021 | $5.1M | -24.6% |
| FY2020 | $6.8M | +3370.3% |
| FY2019 | $195,000 | -73.2% |
| FY2018 | $727,000 | -18.0% |
| FY2017 | $887,000 | -37.9% |
| FY2016 | $1.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice